BioNTech SE (BNTX) Non-Current Assets (2018 - 2025)

BioNTech SE has disclosed Non-Current Assets across 8 years of filings, most recently posting $6.8 billion for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $6.8 billion, up 70.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.8 billion (up 70.79% YoY), and the FY2025 annual result was $6.6 billion, up 65.76% from the prior year.
• Non-Current Assets came in at $6.8 billion for Q4 2025 at BioNTech SE, up from $6.4 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.8 billion in Q4 2025 to a low of $803.3 million in Q3 2021.
• The 5-year median for Non-Current Assets is $3.5 billion (2023), against an average of $3.2 billion.
• Across the five-year window, Non-Current Assets soared 224.44% in 2023 and grew 6.37% in 2024, its largest moves.
• BioNTech SE's Non-Current Assets stood at $867.7 million in 2021, then soared by 59.57% to $1.4 billion in 2022, then soared by 170.35% to $3.7 billion in 2023, then climbed by 6.37% to $4.0 billion in 2024, then soared by 70.79% to $6.8 billion in 2025.
• The last three Non-Current Assets figures came in at $6.8 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.5 billion (Q2 2025), per Business Quant data.